<--- Back to Details
First PageDocument Content
Antihypertensive agents / Organochlorides / Attention-deficit hyperactivity disorder / Stimulants / Imidazolines / Clonidine / Methylphenidate / Transdermal patch / Attention deficit hyperactivity disorder / Chemistry / Organic chemistry / Medicine
Antihypertensive agents
Organochlorides
Attention-deficit hyperactivity disorder
Stimulants
Imidazolines
Clonidine
Methylphenidate
Transdermal patch
Attention deficit hyperactivity disorder
Chemistry
Organic chemistry
Medicine

Clonidine Adverse Event[removed])

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 491,89 KB

Share Document on Facebook

Similar Documents

NOTICE: INFORMATION DE L’UTILISATEUR Catapressan 150 microgrammes comprimés chlorhydrate de clonidine Veuillez lire attentivement cette notice avant d’utiliser ce médicament.  Gardez cette notice. Vous pourriez

DocID: 1le4Q - View Document

NOTICE: INFORMATION DE L’UTILISATEUR Catapressan 150 microgrammes/1 ml Solution injectable/solution pour perfusion chlorhydrate de clonidine Veuillez lire attentivement cette notice avant d’utiliser ce médicament.

DocID: 1kHVW - View Document

NOTICE: INFORMATION DE L’UTILISATEUR Dixarit 0,025 mg comprimés enrobés chlorhydrate de clonidine Veuillez lire attentivement cette notice avant d’utiliser ce médicament car elle contient des informations importan

DocID: 1kDJw - View Document

Psychiatry / Medicine / Neurochemistry / Amphetamine / Methylphenidate / Attention deficit hyperactivity disorder / Psychiatric diagnosis / Attention / Stimulant / Insomnia / Impulsivity / Clonidine

ECHO Access ADHD Management Guideline Attention Deficit Hyperactivity Disorder Management Guideline Attention Deficit Hyperactivity Disorder (ADHD) is an important disorder to be aware of, as it can significantly interf

DocID: 1kqOt - View Document

New Zealand Consumer Medicine Information CATAPRES Tablet and injection Clonidine Hydrochloride

DocID: 1gywA - View Document